Medical Industry Feature: Fertility Outcomes After Hysteroscopic Morcellation of Polyps and Fibroids

Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Fertility Outcomes After Hysteroscopic Morcellation of Polyps and Fibroids

Dr. Serena Chen and Dr. Michael Scheiber assess fertility outcomes in infertile women after hysteroscopic morcellation of intrauterine lesions.
  • Sponsored by

  • Overview

    Join Dr. Serena Chen, Director of Reproductive Medicine at the Institute for Reproductive Medicine and Science at Saint Barnabas in New Jersey, and Dr. Michael Scheiber, Director of Reproductive Research and Co-Director of In Vitro Fertilization Services at the Institute for Reproductive Health in Cincinnati, Ohio, as they discuss fertility outcomes after hysteroscopic procedures. 

    This activity will address the clinical issue of infertility due to intrauterine pathology, best practices for treatment, and reflect on the results of an associated study in the Journal of Reproductive Medicine that looked retrospectively at women with intrauterine pathology and infertility or recurrent pregnancy loss who underwent Hysteroscopic polypectomy and myomectomy.

    Click here for more women's health programs brought to you by Hologic.

  • Important Safety Information (ISI)

    The MyoSure® hysteroscopic tissue removal system is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps and retained products of conception. It is not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies or previously diagnosed uterine cancer.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.